T1	Participants 60 116	men treated for symptomatic benign prostatic hyperplasia
T2	Participants 224 313	men with lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH).
T3	Participants 373 398	men aged > or = 50 years,
T4	Participants 690 702	372 patients
T5	Participants 812 914	64% of the patients reported erectile dysfunction (ED) and 63% reported ejaculatory dysfunction (EjD).